Traditional and Digital Biomarkers: Two Worlds Apart?
-
Published:2019-08-16
Issue:2
Volume:3
Page:92-102
-
ISSN:2504-110X
-
Container-title:Digital Biomarkers
-
language:en
-
Short-container-title:Digit Biomark
Author:
Babrak Lmar M.,
Menetski Joseph,
Rebhan Michael,
Nisato Giovanni,
Zinggeler Marc,
Brasier Noé,
Baerenfaller Katja,
Brenzikofer Thomas,
Baltzer Laurenz,
Vogler Christian,
Gschwind Leo,
Schneider Cornelia,
Streiff Fabian,
Groenen Peter M.A.,
Miho EnkelejdaORCID
Subject
General Engineering
Reference21 articles.
1. Bays HE, Chapman RH, Grandy S; SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007 May;61(5):737–47.
2. Kar S, Paglialunga S, Islam R. Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies. J Clin Pharmacol. 2018 Oct;58(10):1239–47.
3. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010 May;28(5):436–40.
4. Kraus VB. Biomarkers as drug development tools: discovery, validation, qualification and use. Nat Rev Rheumatol. 2018 Jun;14(6):354–62.
5. Allinson JL. Clinical biomarker validation. Bioanalysis. 2018 Jun;10(12):957–68.
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献